BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11286151)

  • 1. Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients.
    Thompson PL
    Atheroscler Suppl; 2001 Feb; 2(1):15-9. PubMed ID: 11286151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early initiation of statin therapy after a coronary event.
    McKeown B; Thompson PL
    Curr Opin Lipidol; 2002 Dec; 13(6):631-5. PubMed ID: 12441887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events.
    Arntz HR
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S17-21. PubMed ID: 10575058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
    Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin].
    Raddino R; Della Pina P; Gorga E; Caretta G; Madureri A; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):78S-83S. PubMed ID: 21416832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early statin treatment in acute coronary syndrome. Is this evidence-based?].
    Jensen LO; Hansen HS
    Ugeskr Laeger; 2002 Jul; 164(27):3519-22. PubMed ID: 12116678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.
    Ray KK; Cannon CP
    Curr Opin Lipidol; 2004 Dec; 15(6):637-43. PubMed ID: 15529022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit.
    Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM
    Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators.
    Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A;
    J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials.
    Bavry AA; Mood GR; Kumbhani DJ; Borek PP; Askari AT; Bhatt DL
    Am J Cardiovasc Drugs; 2007; 7(2):135-41. PubMed ID: 17503884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early statin initiation and outcomes in patients with acute coronary syndromes.
    Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
    JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early statin therapy in acute coronary syndromes.
    Kinlay S
    Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.